Answers are grounded in this paper and cite their sources.
In order to control the neurological complications associated with HIV, it is pertinent to consider the development of an effective antioxidant therapy.The current study was targeted to evaluate the antioxidant capacities of secondary metabolites isolated from Himalayan high-altitude medicinal plants using a standard oxygen radical absorbance capacity assay based on fluorescein (ORAC-Fl assay).Secondary metabolites (SMs) 1-6 were found to be effective in reducing gp120-41 and Tat-generated oxidative stress in SK-N-SH cell lines, quantitated using a fluorescent probe, 5(6)-carboxy-2,7-dichlorofluorescein diacetate (CDFH-DA).These encouraging in vitro preliminary findings suggest that the use of these secondary metabolites may result in the creation of an effective antioxidant therapy that could be used to prevent, delay, or even treat neurological complications linked to oxidative stress caused by HIV proteins.
No takes yet. Share an insight, caveat, or question.
Kulkarni et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: